NewsBenzingaPiper Sandler maintient une recommandation neutre sur LENZ Therapeutics et abaisse son objectif de cours à 5 $ Piper Sandler maintient une recommandation neutre sur LENZ Therapeutics et abaisse son objectif de cours à 5 $ Benzinga 2026.10.19 16:22 (GMT+0) Open on Benzinga Other news Scotiabank Maintains Sector Outperform on Kelt Exploration, Raises Price Target to C$13.5 Scotiabank Maintains Sector Outperform on International Petroleum, Raises Price Target to C$44 Scotiabank Maintains Sector Perform on Imperial Oil, Raises Price Target to C$183 Grupo Aeromexico Raises FY2026 Sales Guidance from $6.050B-$6.120B to $6.085B-$6.138B vs $6.188B Est Grupo Aeromexico Sees Q4 Sales $1.639B-$1.668B vs $1.734B Est Scotiabank Maintains Sector Outperform on Cenovus Energy, Raises Price Target to C$56
